Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors
H. Stewart Parker Departing from Board SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) — Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical…